chr3-100279726-C-T
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 2P and 3B. PM2BP4_ModerateBS1_Supporting
The NM_001199198.3(TBC1D23):c.131C>T(p.Pro44Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000654 in 1,605,314 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001199198.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TBC1D23 | NM_001199198.3 | c.131C>T | p.Pro44Leu | missense_variant | 2/19 | ENST00000394144.9 | |
TBC1D23 | NM_018309.5 | c.131C>T | p.Pro44Leu | missense_variant | 2/18 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TBC1D23 | ENST00000394144.9 | c.131C>T | p.Pro44Leu | missense_variant | 2/19 | 1 | NM_001199198.3 | P3 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152086Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000967 AC: 24AN: 248318Hom.: 0 AF XY: 0.0000819 AC XY: 11AN XY: 134338
GnomAD4 exome AF: 0.0000674 AC: 98AN: 1453228Hom.: 0 Cov.: 29 AF XY: 0.0000637 AC XY: 46AN XY: 722690
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152086Hom.: 0 Cov.: 32 AF XY: 0.0000539 AC XY: 4AN XY: 74266
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 11, 2024 | The c.131C>T (p.P44L) alteration is located in exon 2 (coding exon 2) of the TBC1D23 gene. This alteration results from a C to T substitution at nucleotide position 131, causing the proline (P) at amino acid position 44 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at